Status:
COMPLETED
The Epidemiology of Ventricular Assist Device-Related Infections
Lead Sponsor:
Icahn School of Medicine at Mount Sinai
Collaborating Sponsors:
National Heart, Lung, and Blood Institute (NHLBI)
Conditions:
Congestive Heart Failure
Eligibility:
All Genders
18+ years
Brief Summary
Infections often occur after ventricular assist devices (VADs) are placed. These infections can be very serious. The goal of this study is to understand why these infections occur. Bacteria (germs) no...
Detailed Description
Infections are one of the most serious of ventricular assist device (VAD) related complications. Many of these infections are associated with significant patient morbidity and mortality. Diagnosis of ...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Age greater than or equal to 18 years.
- Approved by the institution's heart failure/transplant committee for VAD implantation, either as a bridge to cardiac transplantation or for destination therapy for end-stage heart failure.
- Signed informed consent, release of medical information, and HIPAA forms.
- Expectation of compliance with protocol procedures and study visit schedule.
Exclusion
Key Trial Info
Start Date :
January 1 2006
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 1 2009
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT01471795
Start Date
January 1 2006
End Date
January 1 2009
Last Update
November 16 2011
Active Locations (13)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Alabama at Birmingham
Birmingham, Alabama, United States, 35294
2
Sharp Memorial Hospital
San Diego, California, United States, 92123
3
Advocate Christ Medical Center
Oak Lawn, Illinois, United States, 60453
4
Jewish Hospital
Louisville, Kentucky, United States, 40202